Results 291 to 300 of about 5,289,946 (346)
Quality of Life of Colorectal Cancer Patients Treated with Chemotherapy. [PDF]
Ziętarska M, Małgorzewicz S.
europepmc +1 more source
Solid predominant lung adenocarcinoma exhibits an immune‐excluded, ferroptosis‐resistant niche enriched with IL4I1⁺ TAMs and TDO2⁺ myCAFs. Spatial and multi‐omics analyses reveal AhR‐driven crosstalk that promotes T cell exhaustion and therapy resistance. Blocking AhR with CH‐223191 restores ferroptosis sensitivity, and its combination with ferroptosis
Zhaoxuan Wang +16 more
wiley +1 more source
SREBP2 confers ferroptosis resistance by targeting GPX4 in colorectal cancer. [PDF]
Zhong H +12 more
europepmc +1 more source
The KDM6B/SLC10A2 Axis Suppresses MDSCs Recruitment via ERK/AP‐1 Signaling in Colorectal Cancer
In wild‐type intestinal epithelial cells, KDM6B demethylates SLC10A2 to promote its expression, after which SLC10A2 suppresses ERK phosphorylation, inhibiting AP‐1 (Fos/Jun) transcription and chemokine production. In KDM6B‐deficient intestinal epithelial cells, SLC10A2 methylation increases, and its expression decreases.
Zhibo Hu +16 more
wiley +1 more source
Five-Year Experience of Nationwide Implementation of Colorectal Cancer Screening in Sweden. [PDF]
Hreinsson JP +4 more
europepmc +1 more source
Diagnostic value of multi-gene methylation in colorectal cancer screening. [PDF]
Yang Q, Chen L.
europepmc +1 more source
Expression and Clinical Significance of CD47 in Colorectal Cancer: A Review. [PDF]
Li Q +9 more
europepmc +1 more source

